To evaluate the contribution of mononuclear phagocytes, and particularly alveolar macrophages, to alpha-l-antitrypsin (alAT) production in normal and alAT-deficient individuals, Northern analysis with a human alAT complementary DNA was used to demonstrate that alAT messenger RNA (mRNA) can be detected in liver, blood monocytes, and alveolar macrophages.
Introduction
Alpha-l-antitrypsin (alAT),' a 52,000-D serum glycoprotein, is the major inhibitor ofneutrophil elastase, a destructive enzyme capable ofcleaving all ofthe major connective tissue components of the extracellular matrix of most tissues (1) (2) (3) (4) (5) . The primary site of action of alAT is the lower respiratory tract, where it protects the alveolar walls against destruction and hence emphysema (1) (2) (3) (6) (7) (8) (9) (10) . When the serum level of a lAT is below 80 mg/dl (normal 150-350 mg/dl), as occurs in the hereditary disorder of alAT deficiency, there is insufficient alAT in the lower respiratory tract to inhibit the burden of elastase, and the affected individual develops emphysema, usually in the third to fourth decade (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) .
The human a lAT gene is present in a single 10.2-kilobase hepatocytes in culture all produce a lAT (17) (18) (19) (20) (21) (22) . Furthermore, liver a lAT mRNA has been translated in vitro, has been used to direct Xenopus oocytes to produce c 1AT, and has been used to produce alAT cDNA (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) . In the common PiZZ form of a 1AT deficiency, it is hypothesized that the decreased plasma (and hence lung) levels of a 1AT result from an inability of the alAT protein to be secreted by the hepatocyte (4, 25-27, 33, 34) . Although the mechanism is not completely proven, it is thought to result from an abnormally slow rate of folding ofthe Z protein within the rough endoplasmic reticulum in such a way that the newly synthesized protein does not move at a normal rate to the Golgi complex (4, 35) . As a result, the three carbohydrate side chains added in the rough endoplasmic reticulum to asparaginyl residues at positions 46, 83, and 247 are not trimmed appropriately, leaving high-mannose carbohydrates attached to the Z protein that accumulates in the rough endoplasmic reticulum (4, 15, 16, 36) . In addition to the hepatocytes, it is also known that cells of the mononuclear series, including monocytes, alveolar macrophages, and breast milk macrophages all produce a lAT (27, (37) (38) (39) (40) (41) (42) (43) (44) (45) (46) . Because the level of alAT produced by these cells is thought to be quite low, mononuclear phagocytes have been generally ignored as playing a relevant role in the normal physiology of a lAT or in the pathogenesis ofthe decreased amounts of c lAT found in the PiZZ form of a lAT deficiency. Such a view, however, may be naive. There are large numbers ofmononuclear phagocytes in the body, probably at least 50 X 109 cells (alveolar macrophages, 20 X 109; bone marrow, 8 X 109; blood monocytes, 2 X 109; Kupfer cells, 20 X 109) (47) (48) (49) (50) . Although this is lower than the estimated 180 X 109 hepatocytes in the normal adult liver (50) , it is important to remember that: (a) alveolar macrophages, the mononuclear phagocytes ofthe lower respiratory tract, are located directly at the site where a lAT plays its major role as an antineutrophil elastase and where a IAT deficiency manifests; and (b) alveolar macrophages represent -10% of the cells of the alveolar structures and are constantly renewed by the circulating monocyte pool and by replication in the local milieu (47, 51, 52) .
In this context, the present study was designed to evaluate the potential of human mononuclear phagocytes to produce a IAT by quantifying ac AT messenger RNA (mRNA) levels in blood monocytes and alveolar macrophages and by comparing these levels to that in the liver. Furthermore 
Methods

Study population
Two groups of individuals were evaluated: normals and those with PiZZ alAT deficiency. Diagnosis of PiZZ-type alAT deficiency was made by a combination of measurement of serum a 1 AT levels determined by radial immunodiffusion (Calbiochem-Behring Corp., La Jolla, CA), Pi type by isoelectric focusing of serum, and family studies by demonstrating codominant inheritance (2, 14, 53, 54) . The normal individuals (n = 35) all had normal alAT serum levels (203±15 mg/dl, range 124-340 mg/ dl [all data in this article are presented as mean±standard error of the mean]), and all were of phenotype PiMM (i.e., various combinations of haplotypes Ml, M2, and M3). This group consisted of 13 males and 22 females, age 40±3 yr (range 27-60) and included 23 nonsmokers and 12 smokers (23±9 pack-year). The alAT-deficient group included 13 individuals (Table I ). All had serum alAT levels below 50 mg/dl (31±3 mg/dI, range 20-41 mg/dl) and all had emphysema as defined by conventional criteria (55) .
Cell types evaluated
The cells evaluated included normal human liver, a human hepatoma cell line (SK-HEP-1), a human fetal liver cell line (CLCL), normal (PiMM) blood monocytes, normal (PiMM) blood lymphocytes, normal (PiMM) blood neutrophils, normal (PiMM) alveolar macrophages, PiZZ alATdeficient blood monocytes, PiZZ alAT-deficient alveolar macrophages, Blood cells. Blood cells were obtained from heparinized venous blood, buffy coat preparations, and leukophoresis. Blood was fractionated by density-gradient centrifugation (LSM, Litton Bionetics, Kensington, MD) into mononuclear cells and granulocytes. Monocytes were purified from the mononuclear cell layer by adherence to plastic in RPMI-1640 medium with 10% FBS, I h, 37°C as described by Johnson et al. (58) . The monocytes were >70% pure as assessed by morphology and nonspecific esterase staining (59) . Lymphocytes were purified from the nonadherent mononuclear cells using an additional overnight adherence step at 37°C in RPMI-1640 (Whittaker, M. A. Bioproducts) with 10% FBS; the nonadherent cells were >90% pure lymphocytes. Neutrophils were purified from the pellet of the buffy coat density-gradient centrifugation by sedimentation on Plasmagel (Cellular Products, Buffalo, NY). The resulting neutrophil preparation was >95% pure as shown by morphology after staining with DiffQuik (American Scientific Products, McGaw Park, IL).
Alveolar macrophages. Alveolar macrophages were obtained by bronchoalveolar lavage using a total of 300 ml of saline as five 20-ml aliquots in each ofthree sites as previously described (60) . Cell differentials were determined using filter preparations as described by Saltini et al. (61) . Samples were utilized only if the return of the infused saline was >20%, and if the contamination by bronchial cells was below 5%. In all cases bronchoalveolar lavage cell suspension was composed of >70% macrophages (84±2%) and <10% neutrophils (3±5%). The viability of alveolar macrophages as assessed by blue trypan exclusion was >90% in all cases.
Mononuclear phagocyte cell line. U-937, a human monocyte-like cell line (ATCC CRL1593) was cultured in RPMI-1640 with 10% FBS, at 370C, in 95% air/5% C02, at a density of 0.5 x 106 cells/ml (62) .
Human lungfibroblasts. The human fetal lung fibroblasts strain HFL-I (ATCC CCL153) was grown in DME with 10% FBS at 37°C with 90% air/10% C02, until confluence (63) .
Extraction oftotal cellular RNA Total cellular RNA was extracted from liver tissue by treatment with guanidine thiocyanate and repeated guanidine hydrochloride extractions (64) . RNA was extracted from all other cell samples by treatment with guanidine hydrochloride and cesium chloride centrifugation (65, 66) .
To avoid ribonuclease contamination, all reactions were performed in sterile plasticware or in glassware treated with 0.1% diethyl pyrocarbonate for 20 min and heated to 250°C overnight (67, 68). All reagents utilized molecular biology grade chemicals, free of ribonuclease activity (Bethesda Research Laboratories, Gaithersburg, MD, or International Biotechnologies, New Haven, CT) and were (including distilled deionized water), filtered on 0.22-am filters (Falcon Labware, Becton, Dickinson & Co., Oxnard, CA), then treated with 0.1 % diethyl pyrocarbonate and autoclaved. Formamide (Fluka AG, Buchs, Switzerland) was deionized on mixed bed resin (AG501-X8; Biorad Laboratories, Richmond, CA) at 4°C and its purity was assessed by a conductivity <20 US (69) . As a final protection against ribonucleases, all samples were washed in phosphate-buffered saline (PBS, Whittaker, M. A. Bioproducts) containing 10 mM vanadyl ribonucleoside complex (Bethesda Research Laboratories) and 50 gg/ml cycloheximide, prior to extraction (70) .
Liver tissue samples were pulverized in liquid nitrogen using a Polytron (Brinkmann Instruments Co., Westbury, NY) and then blended with 4 The precipitate was recovered by centrifugation (6,000 g, 10 min, 40C) and dissolved in halfthe starting volume of 8 M guanidine hydrochloride, 5 mM dithiothreitol, and 25 mM sodium citrate, pH 7.0. RNA was precipitated in 25 mM acetic acid and 50% (vol/vol) ethanol (-20°C, 3 h). After centrifugation and dissolution in one fourth of the starting volume of 8 M guanidine hydrochloride, 5 mM dithiothreitol, and 25 mM sodium citrate, RNA was ethanol-precipitated. The pellet was washed in ethanol and dissolved in water.
Cells were lysed as a pellet or on tissue culture plates in 6 M guanidine hydrochloride (5 ml/108 cells). After addition of 0.1 vol of 2 M potassium acetate, pH 5.0, the cell lysate was shaken vigorously for 5-10 min. 2 vol of 7.2 mM sarkosyl, 100 mM Tris-HCI, pH 8.0, and 1 g of cesium chloride per 2.5 ml were added, and the cell lysate was layered on a cushion of 5.7 M cesium chloride, 0.1 M EDTA, pH 8.0, and the gradient was centrifuged at 25°C in SW41 rotor, 32,000 rpm, 43 h or SW60 rotor, 44,000 rpm, 22 h, or TLS 100 rotor, 43,000 rpm, 18 h (Beckman Instruments, Inc., Palo Alto, CA); the parameters of the centrifugation were chosen to pellet all cellular RNA. The pellet was dissolved in 100 mM NaCl, 10 mM Tris HCI, pH 7.6, 1 mM EDTA, 17 mM sodium dodecyl sulfate (SDS) and precipitated with ethanol. The yield of the extraction procedure was 75-100%o. All RNA samples were characterized as having intact 18 S and 28 S ribosomal RNA by acridine orange staining (see below) and were dissolved in water (1 mg/ml) and stored in liquid nitrogen vapor.
Northern analysis
Total cellular RNA was fractionated according to its molecular weight by electrophoresis in 1% agarose gel in denaturing conditions (71). The gels were run at 3 V/cm for 4-6 h with buffer recirculation. RNA was denatured at 56°C, 15 min in 10 mM sodium phosphate, pH 7.0, 50% formamide, and 2.2 M formaldehyde. Gel and electrophoresis buffers contained 10 mM sodium phosphate, pH 7.0, and 2.2 M formaldehyde. Gels were stained with acridine orange (30 ,g/ml in 10 mM sodium phosphate buffer, pH 7.0) destained 1 h and examined with ultraviolet light (72) . Transfer to nitrocellulose filter (BA85, Scheicher & Schuell, Inc., Keene, NH) in 20 X SSC (1 X SSC = 150 mM NaCl, 15 mM Na citrate, pH 7.0) and baking were performed according to Thomas (73 Complementary (cDNA) probes and hybridization conditions aIAT mRNA was detected using a full-length human alAT cDNA clone (plasmid pTG603) previously described (31) . Actin mRNA was detected using a human fibroblast cytoplasmic -y-actin cDNA (plasmid pHF yA-1) kindly provided by P. Gunning and L. Kedes (Stanford University) (74) . Both probes were nick translated with [32P]CTP (3,000 Ci/mmol, Amersham Corp.), and the labeled cDNA was purified using NACS Prepac (Bethesda Research Laboratories). This procedure yielded labeled probes with an activity >108 dpm/Mg. As a control for nonspecific hybridization, the plasmid pBR322 without the insert was also labeled in a similar fashion.
Prehybridization was conducted at 42°C, 6 h, in 50% formamide, 5 X SSC, 50 mM sodium phosphate, pH 7.0, 10 x Denhardt's solution (0.2% wt/vol of each of the following: Ficoll 400, polyvinylpyrrolidone, bovine serum albumin), 0.1% SDS, and 250 jig/ml denatured salmon sperm DNA (75 Quantitative evaluation ofthe expression ofthe aJ]AT gene Quantification ofthe expression ofthe a 1AT gene by liver, blood monocytes, and alveolar macrophages was performed using two methods: RNA dot-blot hybridization and Quick-blot.
For RNA dot-blot hybridization, total cellular RNA was denatured at 56°C, 15 min in 7.5 X SSC, 4.4 M formaldehyde and applied to nitrocellulose filter with a Minifold Apparatus (Schleicher & Schuell). The filter was then baked for 2 h, at 80°C and hybridized as described above. The amount of specific hybridization was determined by scanning densitometry of the autoradiograms (Ortec, Oak Ridge, TN). Results were obtained as densitometric units per microgram of RNA. In order to express the results as units per cell, an aliquot oftissue or cell samples was used to measure the amounts of RNA (orcinol reaction) and DNA (diphenylamine reaction) after sodium hydroxide extraction and a value of 10 gg of DNA/106 cells was used (76) (77) (78) (79) .
To assess the expression of the alAT gene in small cell samples, the Quick-blot method was used as described by Bresser et al. (68) , according to the manufacturer's recommendations (Schleicher & Schuell). Filters were hybridized as above. Similar to the RNA dot-blot data, the results were expressed as units per cell. Experiments comparing relative amounts of alAT mRNA/cell using the Quick-blot or RNA dot-blot showed no significant differences.
In vitro maturation ofmonocytes Monocytes were purified as described above and cultured in RPMI-1640 with 10% FBS. The medium was changed once weekly without washing the cells. On days 1, 9, 1 1, and 15, after the beginning of the culture, total cellular RNA was extracted and alAT mRNA levels were quantified as described above using the amount ofRNA and DNA per cell to express the data as alAT mRNA units per cell.
Production and secretion ofalA T by monocytes and alveolar macrophages To evaluate the production and secretion of alAT by alveolar macrophages, 2 X 106 cells recovered by lavage were plated on plastic dishes (30 min; 37°C) in plating medium (methionine-free DME + 10% heatinactivated FBS previously dialyzed against PBS). The cells were washed once with pulse medium (methionine-free DME + 10% dialyzed FBS) and incubated (30 min, 37°C) in pulse medium with 500 uCi/ml [35SJmethionine (1,000 Ci/mmol, New England Nuclear, Boston, MA) (80) . In some experiments, cycloheximide (10 ,ug/ml) was added. The cells were then washed twice with PBS and then chased with medium containing an excess of methionine for 30 min, I h, 2, and 3 h in chase medium (methionine-free DME, 10%o dialyzed FBS, 6 X 10-4 M unlabeled methionine). In all studies, at the end of the chase period, the viability of the cells was >90%. At (Fig. 1) . Northern blot analysis of RNA obtained from normal human liver showed that the a 1 AT gene is expressed in human liver as a single mRNA of 1.75 kb. Consistent with this observation, both hepatoma (SK-HEP-1) and fetal liver (CLCL) cell lines also expressed the alAT gene as a 1.75-kb mRNA. Similarly, cellular RNA extracted from normal alveolar macrophages, normal monocytes, and, to a lesser extent, the monocyte-like cell line U-937, demonstrated the same mRNA species.
The alAT gene was also expressed in normal PiMM blood neutrophils ( Fig. 1 A) as well as in PiZZ neutrophils (not shown). However, alAT mRNA was not detected in normal blood lymphocytes, nor in the human lung fibroblast strain HFL-I (Fig.  1 A) . However, when the same RNA samples were hybridized with a y-actin cDNA, the expected 2.0-kb mRNA was observed in all samples, including lymphocytes and fibroblasts, cells that did not express the alAT gene (Fig. 1 B) . In all cases where hybridization was observed with the alAT cDNA and/oractin cDNA, no hybridization was seen with plasmid pBR322 without the insert.
Relative quantifcation of the expression of the aJAT gene by mononuclearphagocytes. Although mononuclear phagocytes express the a 1 AT gene, their level of expression is lower than that observed in the liver (Fig. 2) Expression ofthe aJAT gene in mononuclear phagocytes of PiZZ individuals. Despite the fact that PiZZ individuals have low a 1 AT serum levels, mononuclear phagocytes from PiZZ patients express the a IAT gene (Fig. 4) . Furthermore, in both monocytes and alveolar macrophages, the level of a1 AT gene expression was similar in PiZZ and PiMM individuals (Fig. 5) . Northern blot analysis of total cellular RNA revealed the presence of a similar species of a1AT mRNA in both monocytes and alveolar macrophages of PiZZ individuals as that of PiMM individuals; in both, the size was 1.75 kb (Fig. 4) . Likewise, quantitative comparison of the mRNA levels showed no significant difference in the amount of a 1 AT mRNA expressed in mononuclear phagocytes between PiZZ and PiMM individuals. This was true for both monocytes (PiMM 0.8±0.2 U/cell vs. PiZZ 1.3±0.4 U/cell, P > 0.5) and alveolar macrophages (PiMM 4.4±0.4 U/cell vs. PiZZ 3.9±0.6 U/cell, P > 0.5) (Fig. 5) . Thus, PiZZ mononuclear phagocytes express the a 1 AT gene in a fashion similar to that of PiMM mononuclear phagocytes.
De novo production and synthesis ofalA T by alveolar macrophages. As expected for cells expressing the a 1 AT gene, alveolar macrophages synthesize and secrete a 1 AT. This was true for alveolar macrophages from both PiMM and PiZZ individuals. Alveolar macrophages incubated with [35S]methionine synthesized and released a variety of proteins into the medium, including a 52-kD protein specifically immunoprecipitated by an anti-a lAT antibody (Fig. 6) . Likewise, blood monocytes also produced and secreted labeled a lAT (data not shown). In all cases, the production of [35S]methionine-labeled a lAT was completely suppressed by noncytotoxic, reversible concentrations ofcycloheximide. As a control, beads not coated with antia I AT did not result in the precipitation of any labeled protein. dividuals also synthesized and secreted alAT, after a 30-min "pulse" with [35S]methionine, at each time point of a 30-min to 3-h chase period, the amount secreted per cell was markedly less than that for PiMM alveolar macrophages of three normal individuals (Fig. 6 ). Controls of de novo synthesis by alveolar macrophages of proteins other than alAT were done by examining the release of fibronectin and antichymotrypsin in the same supernatants. The different Pi phenotypes were not associated with any difference in the release of these control proteins. Furthermore, when the cells were labeled for 24 h, scanning of the autoradiogram ofthe secreted a 1AT demonstrated that PiZZ alveolar macrophages secreted 10-fold less alAT than PiMM alveolar macrophages ( (37) (38) (39) (40) , and that rat alveolar macrophages synthesize alAT (41) as do normal human blood monocytes (27, (42) (43) (44) 46) . Furthermore, Budek et al. (45) have shown that when rat lung mRNA is translated in vitro in a rabbit reticulocyte system, a lAT is produced, and Perlmutter et al. (27, 46) have recently demonstrated alAT mRNA transcripts in normal human monocytes, alyeolar macrophages, and breast milk macrophages with characteristics similar to those that we observed. In addition, the studies of Isaacson et al. (40) showing that liver, spleen, and lymph node macrophages all contain a 1AT are consonant with the concept that all mononuclear phagocytes express the a 1 AT gene.
In addition to mononuclear phagocytes, we noted that neutrophils expressed an a 1AT mRNA transcript, whereas, in contrast, blood lymphocytes and lung fibroblasts did not. These observations are consistent with the finding by Andersen (43, 44) that neutrophils produce alAT and the findings of others that noted lymphocytes and fibroblasts do not (40, 42) . Furthermore, the observation of Rogers et al. (28) that unfractionated blood leukocytes express a1AT mRNA, but less than the liver, is consistent with the concept that not only do blood monocytes express a IAT but that neutrophils do as well.
Modulation of alA T gene expression during mononuclear phagocyte maturation. Consistent with the observation that alveolar macrophages recovered from the lungs of normal individuals contain threefold more alAT mRNA than autologous blood monocytes, in vitro studies demonstrated that when blood monocytes are allowed to"mature" into macrophages in culture, these cells (on a per cell average) contain severalfold more copies of a lAT mRNA than the original blood monocytes. This increase is related to a nonspecific augmentation of total cellular RNA per cell during in vitro maturation. The observation that these alAT-producing cells can modulate the expression of the a IAT gene is consistent with the knowledge that liver cells can modulate aIAT gene expression both in vivo (17, 84) and in vitro (18) , and that alAT plasma levels can be up-regulated in humans, such as that occurs in inflammatory states and with the effect of steroid sex hormones (84) (85) (86) (87) (88) (89) (90) (91) . Our observations appear to be inconsistent with that of Perlmutter et al. (46) , who found a decrease in alAT mRNA during in vitro maturation of monocytes. The reasons for this discrepancy are not clear, but may be related to the fact that we expressed our data on an average per cell basis after accounting for the RNA/DNA ratios in monocytes whereas Perlmutter et al. (46) expressed their data on the basis of RNA. In this context, when our data are evaluated on the basis of RNA without considering the number of cells used from which-the RNA was derived, these observations are similar to the data of Perlmutter et al. (46) . The concept that mononuclear phagocytes modulate the expression of various genes during the maturation process is consistent with the knowledge that the array ofproteins produced by tissue macrophages is both qualitatively and quantitatively different from that of blood monocytes. Included among such proteins are the complement proteins (79, 92, 93) , the transfenin receptor (94) (95) (96) , fibronectin (97), interleukin 1 (97), histocompatibility antigens (98) , and a growth factor (99) .
aJAT gene expression by mononuclear phagocytes in PiZZ alA Tdeficiency. The pathogenesis ofthe decreased plasma levels of alAT in PiZZ individuals is now understood to result from the glu32 to 1ys342 substitution, likely to cause a slow rate of folding ofthe newly synthesized alAT in the RER, allowing the a lAT with its incompletely trimmed carbohydrate side chains to aggregate and precipitate in the RER, and thus not be normally translocated to the Golgi complex and subsequently secreted (4, 35) . Our observations that alveolar macrophages ofPiZZ alATdeficient individuals have normal levels of alAT mRNA yet secrete less a 1 AT are completely consistent with these concepts. It is also completely consistent with the observations that when equal amounts of M and Z alAT mRNA obtained from liver are injected into Xenopus oocytes, the Z-type a 1AT mRNA results in the secretion of less than normal amounts of a 1AT (26, 27) . It is also consistent with the observations of Errington et al. (33) that PiZZ liver translates as efficiently as does PiMM liver mRNA in a wheat germ system and the observations of mRNA. The decreased secretion oflabeled alAT by PiZZ macrophages is consistent with similar results obtained with blood monocytes (27, 42) and liver (34) . Together, these observations suggest that the M to Z substitution of codon AAG for GAG has no effect on the amount of mRNA transcript present in alAT-producing cells. Thus, the concept that a relatively high level of alAT in the extracellular milieu might down-regulate (and thus low levels presumably up-regulate) a 1AT mRNA levels (18) likely does not occur in vivo.
Most importantly, the results of the present study, as well as that of Perlmutter et al. (27, 46) , suggest that mononuclear phagocytes contribute to the adequate levels of alAT present in the lower respiratory tract of normal individuals and the insufficient levels of alAT present in the lower respiratory tract of PiZZ alAT-deficient individuals. Furthermore, these observations strongly suggest that mononuclear phagocytes may provide a readily accessible cell to evaluate the regulation of alAT gene expression in normals and in the variQus states of alAT deficiency. These observations, together with the fact that Ztype mononuclear phagocytes are capable of secreting alAT, lends credence to the concept that with insertion of a normal alAT gene and an appropriate promoter, into bone marrow cells, autologous bone marrow transplantation may provide delivery of increased amounts of alAT to the lower respiratory tract of PiZZ-type alAT-deficient individuals.
